Literature DB >> 19679246

Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.

Ted Feldman1, Saibal Kar, Michael Rinaldi, Peter Fail, James Hermiller, Richard Smalling, Patrick L Whitlow, William Gray, Reginald Low, Howard C Herrmann, Scott Lim, Elyse Foster, Donald Glower.   

Abstract

OBJECTIVES: We undertook a prospective multicenter single-arm study to evaluate the feasibility, safety, and efficacy of the MitraClip system (Evalve Inc., Menlo Park, California).
BACKGROUND: Mitral valve repair for mitral regurgitation (MR) has been performed by the use of a surgically created double orifice. Percutaneous repair based on this surgical approach has been developed by use of the Evalve MitraClip device to secure the mitral leaflets.
METHODS: Patients with 3 to 4+ MR were selected in accordance with the American Heart Association/American College of Cardiology guidelines for intervention and a core echocardiographic laboratory.
RESULTS: A total of 107 patients were treated. Ten (9%) had a major adverse event, including 1 nonprocedural death. Freedom from clip embolization was 100%. Partial clip detachment occurred in 10 (9%) patients. Overall, 79 of 107 (74%) patients achieved acute procedural success, and 51 (64%) were discharged with MR of < or =1+. Thirty-two patients (30%) had mitral valve surgery during the 3.2 years after clip procedures. When repair was planned, 84% (21 of 25) were successful. Thus, surgical options were preserved. A total of 50 of 76 (66%) successfully treated patients were free from death, mitral valve surgery, or MR >2+ at 12 months (primary efficacy end point). Kaplan-Meier freedom from death was 95.9%, 94.0%, and 90.1%, and Kaplan-Meier freedom from surgery was 88.5%, 83.2%, and 76.3% at 1, 2, and 3 years, respectively. The 23 patients with functional MR had similar acute results and durability.
CONCLUSIONS: Percutaneous repair with the MitraClip system can be accomplished with low rates of morbidity and mortality and with acute MR reduction to < 2+ in the majority of patients, and with sustained freedom from death, surgery, or recurrent MR in a substantial proportion (EVEREST I; NCT00209339. EVEREST II; NCT00209274).

Entities:  

Mesh:

Year:  2009        PMID: 19679246     DOI: 10.1016/j.jacc.2009.03.077

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  143 in total

1.  The unique mechanism of functional mitral regurgitation in acute myocardial infarction: a prospective dynamic 4D quantitative echocardiographic study.

Authors:  Toshiyuki Kimura; Véronique L Roger; Nozomi Watanabe; Sergio Barros-Gomes; Yan Topilsky; Shun Nishino; Yoshisato Shibata; Maurice Enriquez-Sarano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-04-01       Impact factor: 6.875

2.  Mitral valve analysis using a novel 3D holographic display: a feasibility study of 3D ultrasound data converted to a holographic screen.

Authors:  Jan Otto Beitnes; Lars Gunnar Klæboe; Jørn Skaarud Karlsen; Stig Urheim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

3.  Valve interventions-a word of caution.

Authors:  Joana Osório; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-07       Impact factor: 32.419

4.  [Disappearing borders between cardiology and cardiothoracic surgery: status quo].

Authors:  R Bekeredjian; T Schilling; H A Katus; A Haverich
Journal:  Chirurg       Date:  2010-12       Impact factor: 0.955

5.  MitraClip and Transcatheter Aortic Valve Implantation (TAVI): State of the Art 2015.

Authors:  Alessandro Candreva; Francesco Maisano; Maurizio Taramasso
Journal:  Curr Heart Fail Rep       Date:  2015-12

Review 6.  Contemporary application of the edge-to-edge repair.

Authors:  Alberto Pozzoli; Luca Vicentini; Michele De Bonis; Giovanna Di Giannuario; Giovanni La Canna; Ottavio Alfieri
Journal:  Ann Cardiothorac Surg       Date:  2015-07

7.  Deep sedation versus general anesthesia in percutaneous edge-to-edge mitral valve reconstruction using the MitraClip system.

Authors:  Suzanne de Waha; Joerg Seeburger; Joerg Ender; Steffen Desch; Ingo Eitel; Adrian Reinhardt; Janine Pöss; Georg Fuernau; Thilo Noack; Denis Rouven Merk; Gerhard Schuler; Hans-Hinrich Sievers; Friedrich-Wilhelm Mohr; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2015-12-18       Impact factor: 5.460

Review 8.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 9.  The Evolving Role of Percutaneous Mitral Valve Repair.

Authors:  Merrill H Stewart; J Stephen Jenkins
Journal:  Ochsner J       Date:  2016

10.  Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Carsten Schwencke; Klaudija Bijuklic; Taoufik Ouarrak; Edith Lubos; Wolfgang Schillinger; Björn Plicht; Holger Eggebrecht; Stephan Baldus; Gerhard Schymik; Peter Boekstegers; Rainer Hoffmann; Jochen Senges; Joachim Schofer
Journal:  Clin Res Cardiol       Date:  2016-10-17       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.